|
CH528514A
(de)
|
1969-05-22 |
1972-09-30 |
Bayer Ag |
Verfahren zur Herstellung von Acylimidazolen
|
|
US4721712A
(en)
|
1984-06-12 |
1988-01-26 |
Pfizer Inc. |
1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
|
|
CN1030415A
(zh)
|
1987-02-20 |
1989-01-18 |
山之内制药株式会社 |
饱和的杂环碳酰胺衍生物和它的制备方法
|
|
JP2829451B2
(ja)
*
|
1990-11-30 |
1998-11-25 |
大塚製薬株式会社 |
活性酸素抑制剤
|
|
US5120749A
(en)
|
1991-02-20 |
1992-06-09 |
Abbott Laboratories |
Platelet activating antagonists
|
|
GB2260704B
(en)
|
1991-09-30 |
1995-08-23 |
Philip Richardson |
Suturing apparatus
|
|
NO924963L
(no)
*
|
1991-12-27 |
1993-06-28 |
Sankyo Co |
Pyridyltiazolidinkarboksylsyreamid-derivater og fremgangsmaate til fremstilling derav
|
|
JP3393891B2
(ja)
|
1992-08-18 |
2003-04-07 |
塩野義製薬株式会社 |
イミダゾール類の製造方法
|
|
US5514690A
(en)
|
1992-11-17 |
1996-05-07 |
E. R. Squibb & Sons, Inc. |
Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
|
|
JP2550915B2
(ja)
|
1994-06-21 |
1996-11-06 |
日本電気株式会社 |
印刷配線板の表面保護剤および表面保護膜の形成方法
|
|
DK0798298T3
(da)
|
1994-12-15 |
2001-10-22 |
Sankyo Co |
Thiazolidinon- eller oxazolidonderivater til behandling af angina pectoris eller sammensætninger indeholdende samme som aktiv bestanddel
|
|
KR100292737B1
(ko)
|
1995-03-02 |
2001-09-17 |
가와무라 요시부미 |
광학활성인티아졸리디논유도체
|
|
WO1999001128A1
(en)
|
1997-07-03 |
1999-01-14 |
Neurogen Corporation |
Certain diarylimidazole derivatives; a new class of npy specific ligands
|
|
JP2004067510A
(ja)
|
1997-12-26 |
2004-03-04 |
Mitsubishi Pharma Corp |
新規イミダゾール誘導体
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
AU7354900A
(en)
|
1999-09-09 |
2001-04-10 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
JP2001240593A
(ja)
*
|
1999-10-12 |
2001-09-04 |
Japan Tobacco Inc |
高トリグリセリド血症治療薬及び抗肥満薬
|
|
AU2284001A
(en)
|
1999-12-27 |
2001-07-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
|
|
DK1286964T3
(da)
|
2000-05-11 |
2007-10-01 |
Univ Madrid Autonoma |
Heterocykliske inhibitorer glycogensynthasekinase GSK-3
|
|
EP1347971B1
(en)
|
2000-12-21 |
2006-03-01 |
Bristol-Myers Squibb Company |
Thiazolyl inhibitors of tec family tyrosine kinases
|
|
WO2002085899A1
(en)
|
2001-04-19 |
2002-10-31 |
Vertex Pharmaceuticals Incorporated |
Heterocyclyldicarbamides as caspase inhibitors
|
|
WO2003016338A1
(en)
|
2001-08-15 |
2003-02-27 |
Parker Hughes Institute |
Crystal structure of the btk kinase domain
|
|
TWI231757B
(en)
*
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
HN2002000266A
(es)
*
|
2001-09-24 |
2003-11-16 |
Bayer Corp |
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
|
|
WO2003027105A1
(en)
*
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors
|
|
US20040267017A1
(en)
*
|
2001-09-26 |
2004-12-30 |
Bierer Donald E |
3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
|
|
US20050014805A1
(en)
|
2001-10-12 |
2005-01-20 |
Chenzhi Zhang |
Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
|
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
|
US7071218B2
(en)
*
|
2001-11-15 |
2006-07-04 |
Incyte San Diego Incorporated |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
|
|
BR0308816A
(pt)
*
|
2002-04-08 |
2005-03-22 |
Torrent Pharmaceuticals Ltd |
Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas
|
|
WO2003090680A2
(en)
|
2002-04-23 |
2003-11-06 |
Axys Pharmaceuticals, Inc. |
Novel phenyl derivatives as inducers of apoptosis
|
|
TW200404796A
(en)
*
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
|
WO2004052280A2
(en)
|
2002-12-10 |
2004-06-24 |
Imclone Systems Incorporated |
Anti-angiogenic compounds and their use in cancer treatment
|
|
AU2004212490B2
(en)
|
2003-02-10 |
2008-05-15 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
AU2004210711B2
(en)
|
2003-02-12 |
2010-07-08 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
PL378919A1
(pl)
|
2003-04-10 |
2006-06-12 |
Avanir Pharmaceuticals |
Pochodne imidazolu do leczenia zaburzeń alergicznych i nadmiernego rozrostu
|
|
WO2004093873A1
(en)
|
2003-04-17 |
2004-11-04 |
Janssen Pharmaceutica, N.V. |
2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
|
|
WO2004103960A2
(en)
|
2003-05-16 |
2004-12-02 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
|
US6787245B1
(en)
|
2003-06-11 |
2004-09-07 |
E. I. Du Pont De Nemours And Company |
Sulfonated aliphatic-aromatic copolyesters and shaped articles produced therefrom
|
|
BRPI0412893A
(pt)
|
2003-07-24 |
2006-10-03 |
Leo Pharma As |
composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
|
|
WO2005014534A1
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US20060014740A1
(en)
*
|
2003-11-18 |
2006-01-19 |
Miller Duane D |
Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
|
|
CN1902184A
(zh)
|
2003-11-18 |
2007-01-24 |
田纳西大学研究基金会 |
噻唑烷酮酰胺、噻唑烷羧酸酰胺、其制备方法及其用途
|
|
WO2005058834A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
WO2005080367A1
(en)
*
|
2004-02-12 |
2005-09-01 |
Pharmagene Laboratories Limited |
Ep2 receptor agonists
|
|
US20070191448A1
(en)
|
2004-03-08 |
2007-08-16 |
Robert Zelle |
Ion channel modulators
|
|
AU2005325271A1
(en)
*
|
2004-05-06 |
2006-07-27 |
Plexxikon, Inc. |
PDE4B inhibitors and uses therefor
|
|
WO2006002119A2
(en)
|
2004-06-18 |
2006-01-05 |
Gpc Biotech, Inc. |
Kinase inhibitors for treating cancers
|
|
PL1781649T3
(pl)
*
|
2004-08-17 |
2009-01-30 |
Hoffmann La Roche |
Podstawione hydantoiny
|
|
US20060211603A1
(en)
*
|
2004-08-18 |
2006-09-21 |
Vicuron Pharmaceuticals Inc. |
Ramoplanin derivatives possessing antibacterial activity
|
|
EP1627876A1
(en)
|
2004-08-20 |
2006-02-22 |
Ferring B.V. |
Heterocyclic condensed compounds useful as antidiuretic agents
|
|
EP1637529A1
(en)
|
2004-09-20 |
2006-03-22 |
4Sc Ag |
Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
|
|
MX2007006739A
(es)
*
|
2004-12-13 |
2007-08-02 |
Leo Pharma As |
Compuestos de aminobenzofenona sustituidos con triazol.
|
|
JP5236293B2
(ja)
|
2005-01-13 |
2013-07-17 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｘｉａ因子阻害剤としての置換ビアリール化合物
|
|
AU2006204724A1
(en)
*
|
2005-01-14 |
2006-07-20 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
|
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
EP2354139A1
(en)
|
2005-05-20 |
2011-08-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
EP1926487A2
(en)
|
2005-07-19 |
2008-06-04 |
University of Tennessee Research Foundation |
Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
|
|
SG172738A1
(en)
|
2005-07-29 |
2011-07-28 |
4Sc Ag |
Novel heterocyclic nf-kb inhibitors
|
|
US8030339B2
(en)
*
|
2005-10-14 |
2011-10-04 |
Neurosearch A/S |
Imidazole derivatives for the treatment of anxiety and related diseases
|
|
USRE46792E1
(en)
*
|
2005-11-15 |
2018-04-17 |
Otsuka Pharmaceutical Co., Ltd. |
Oxazole compound and pharmaceutical composition
|
|
WO2007082808A2
(en)
|
2006-01-18 |
2007-07-26 |
F. Hoffmann-La Roche Ag |
Thiazoles as 11 beta-hsd1 inhibitors
|
|
US7612212B2
(en)
|
2006-02-22 |
2009-11-03 |
Hoffmann-La Roche Inc. |
Substituted hydantoins
|
|
EP1832585A1
(en)
*
|
2006-03-10 |
2007-09-12 |
ORIDIS BIOMED Forschungs- und Entwicklungs GmbH |
Thiazole-piperidine derivatives for treatment of hyperproliferative diseases
|
|
EP1834954A1
(en)
*
|
2006-03-15 |
2007-09-19 |
4Sc Ag |
Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
|
|
WO2007115805A2
(en)
|
2006-04-05 |
2007-10-18 |
European Molecular Biology Laboratory (Embl) |
Aurora kinase inhibitors
|
|
WO2007146230A2
(en)
|
2006-06-14 |
2007-12-21 |
Merck & Co., Inc. |
Non-nucleoside reverse transcriptase inhibitors
|
|
AR061981A1
(es)
|
2006-07-13 |
2008-08-10 |
Bayer Cropscience Sa |
Derivados de hidroximoil-tetrazol fungicidas
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
CN102850324A
(zh)
*
|
2006-08-07 |
2013-01-02 |
硬木药品公司 |
吲哚化合物
|
|
PL2050749T3
(pl)
*
|
2006-08-08 |
2018-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Pochodna pirymidyny jako inhibitor pi3k i jej zastosowanie
|
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
|
EP2061761A1
(en)
*
|
2006-09-07 |
2009-05-27 |
Millennium Pharmaceuticals, Inc. |
Phenethylamide derivatives with kinase inhibitory activity
|
|
KR100932093B1
(ko)
|
2006-09-27 |
2009-12-16 |
주식회사종근당 |
미세소관 형성 저해제로서 유용한 벤조페논 유도체
|
|
EP2125778A1
(en)
|
2006-12-22 |
2009-12-02 |
Millennium Pharmaceuticals, Inc. |
Certain pyrazoline derivatives with kinase inhibitory activity
|
|
WO2008128179A1
(en)
|
2007-04-14 |
2008-10-23 |
The University Of Tennessee Research Foundation |
Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
|
|
US20090142832A1
(en)
|
2007-11-29 |
2009-06-04 |
James Dalton |
Indoles, Derivatives, and Analogs Thereof and Uses Therefor
|
|
US8389567B2
(en)
|
2007-12-12 |
2013-03-05 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
MX2010014066A
(es)
|
2008-06-16 |
2011-06-01 |
Univ Tennessee Res Foundation |
Compuestos para el tratamiento del cancer.
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
US9029408B2
(en)
*
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
PL3560498T3
(pl)
|
2009-10-16 |
2022-12-12 |
Novartis Ag |
Kombinacja zawierająca inhibitor mek i inhibitor b-raf
|
|
KR101134194B1
(ko)
|
2009-12-03 |
2012-04-09 |
서울대학교산학협력단 |
헤테로바이아릴피리딘 유도체 화합물의 제조방법 및 이러한 방법에 의해 제조된 헤테로바이아릴피리딘 유도체 화합물
|
|
RU2581367C2
(ru)
|
2010-03-01 |
2016-04-20 |
Джи Ти Икс, ИНК. |
Соединения для лечения рака
|
|
US8426418B2
(en)
|
2010-08-27 |
2013-04-23 |
CollabRx Inc. |
Method to treat melanoma in BRAF inhibitor-resistant subjects
|
|
CN103443725B
(zh)
|
2011-03-29 |
2015-07-29 |
三菱电机株式会社 |
伺服控制装置的异常诊断装置及异常诊断系统
|
|
SG194052A1
(en)
|
2011-04-01 |
2013-11-29 |
Genentech Inc |
Combinations of akt inhibitor compounds and erlotinib, and methods of use
|
|
ME02316B
(me)
|
2011-04-07 |
2016-06-20 |
Bayer Ip Gmbh |
Imidazopiridazini kao inhibitori akt kinaze
|
|
JP6835472B2
(ja)
*
|
2013-03-05 |
2021-02-24 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
癌の処置のための組成物
|